Tecfidera ‘could be increasing B-cells’
Posted: Mon Apr 04, 2016 7:11 am
Recent studies have shown that Tecfidera decreased certain immune cells, of both B-, and T-cell type in MS patients. Studies have also indicated that this class of drugs affects the signalling through IL-10, a key regulator of immune responses. This anti-inflammatory cytokine is most often released by regulatory B-, and T-cells (Bregs/Tregs)...Read more - http://www.ms-uk.org/MSnews